MannKind Study to assess safety, efficacy and treatment experience of starting inhaled insulin in youth aged 10 to
The US Food and Drug Administration (FDA) has approved an updated label for insulin human (Afrezza) inhalation powder, which provides guidance for starting dosages when switching from multiple daily injections…